Sareum Holdings
OverviewSuggest Edit
Sareum Holdings discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. The Company's drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate. Sareum Holdings develops therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The Company’s product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, TYK2 kinase-autoimmune diseases and TYK2 kinase-cancer.
| Type | Public | |
| Founded | 2003 | |
| HQ | Pampisford, GB | Map |
| Website | sareum.com |
Locations
Latest Updates
| Employees (est.) (Aug 2017) | 2 |
Sareum Holdings Office Locations
Sareum Holdings Online and Social Media Presence
904 Twitter followers
Sareum Holdings has 904 Twitter Followers. The number of followers has decreased 0.1% quarter over quarter
Sareum Holdings's Trends
Twitter Engagement Stats for @Sareumplc
309
Tweets
438
Following
904
Followers
3
Tweets last 30 days
10.7
Avg. likes per Tweet
100%
Tweets with engagement
Sareum Holdings Frequently Asked Questions
When was Sareum Holdings founded?
Sareum Holdings was founded in 2003.
How many employees does Sareum Holdings have?
Sareum Holdings has 2 employees.
Who are Sareum Holdings competitors?
Competitors of Sareum Holdings include Innocare, MolMed and Cleave Biosciences.
Where is Sareum Holdings headquarters?
Sareum Holdings headquarters is located at 2a Langford Arch London Rd, Pampisford.
Where are Sareum Holdings offices?
Sareum Holdings has an office in Pampisford.
How many offices does Sareum Holdings have?
Sareum Holdings has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies